Medicine and Dentistry
Arm
10%
Biological Marker
8%
Brain Tumor
17%
Cancer
24%
Cancer Cell
13%
Carcinogenesis
10%
Cell Transdifferentiation
8%
Clear Cell Renal Cell Carcinoma
16%
Cytotoxic T-Cell
16%
Drug Response
9%
Durvalumab
10%
Female Genital Tract Cancer
8%
Ganglioglioma
39%
Glioblastoma
100%
Glioma Stem Cell
12%
Immunotherapy
8%
Kidney Cancer
8%
Lung Cancer
8%
Malignant Neoplasm
24%
Metastatic Carcinoma
12%
Metastatic Colorectal Cancer
8%
Molecular Profiling
12%
Neoplasm
69%
Neuropilin 1
8%
Nodular Melanoma
14%
Non Small Cell Lung Cancer
9%
Oncogene
8%
Oncology
9%
Pazopanib
12%
Pharmacogenetic Testing
8%
Pharmacogenomics
26%
Phase II Trials
9%
Phosphotransferase
12%
Progression Free Survival
15%
Radiation Therapy
10%
Recurrent Disease
14%
Ring Finger
8%
Semaphorin 3A
8%
Soft Tissue Sarcoma
12%
Sterol Regulatory Element Binding Protein 1c
8%
Stomach Tumor
8%
Targeted Therapy
12%
Temozolomide
15%
Therapeutic Agent
8%
Therapeutic Procedure
17%
Treatment Response
13%
Tumor Cell
14%
Tumor Microenvironment
12%
Tumor Progression
21%
Tumor Recurrence
9%
Biochemistry, Genetics and Molecular Biology
Bevacizumab
8%
Cancer Cell
16%
Carcinogenesis
9%
Coculture
8%
DNA Template
8%
down Regulation
9%
Drive
12%
Drug Response
8%
Drug Screening
10%
Dynamics
10%
Exome Sequencing
15%
Exon
12%
G Protein Coupled Receptor
10%
G Protein Coupled Receptor
8%
Galactosidase
8%
Gene Mutation
11%
Genetic Trait
8%
Genetics
8%
IDH1
8%
Isocitrate Dehydrogenase
17%
Isoform
8%
Kirsten Murine Sarcoma Virus
8%
Leucine-Rich Repeat
8%
Messenger RNA
12%
Microsatellite DNA
9%
Missense Mutation
8%
Mouse
14%
Myeloid
8%
Next Generation Sequencing
8%
Oncogene
9%
Overall Survival
9%
Pharmacogenomics
12%
Proteogenomics
8%
Radiosensitivity
13%
Radiosensitivity
8%
RNA Interference
17%
RNA Sequence
15%
Secretion (Process)
8%
Signaling Mechanism
8%
Smelling
8%
Stem Cell
31%
Synapsin I
8%
T Cell
12%
Tissue Factor
8%
Tumor Progression
14%
Tumor Suppressor Gene
8%
Tumor Suppressor Protein
9%
Tumor-Associated Macrophage
14%
USP1
8%
Wild Type
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antiangiogenic Therapy
9%
Bevacizumab
15%
Biological Marker
11%
Carcinogenesis
9%
Castration Resistant Prostate Cancer
8%
Cell Marker
5%
Chemotherapy
5%
Colon Cancer
8%
Epidermal Growth Factor Receptor
6%
Epidermal Growth Factor Receptor Antibody
8%
Female Genital Tract Cancer
8%
Female Genital Tract Tumor
8%
Glioblastoma
82%
Hypophysis Tumor
8%
Intrinsic Resistance
8%
Isocitrate Dehydrogenase 1
6%
Kidney Cancer
8%
Lung Cancer
8%
Macitentan
8%
Malignant Neoplasm
15%
Melanoma
7%
Metastasis
15%
Metastatic Colorectal Cancer
5%
Neoplasm
42%
Neoplasm
16%
Pancreas Adenocarcinoma
5%
Pazopanib
8%
Pharmacogenomics
12%
Phosphotransferase
9%
Programmed Death 1 Ligand 1
8%
Progression Free Survival
9%
Recurrent Disease
9%
Renal Cell Carcinoma
12%
Semaphorin 3A
8%
Soft Tissue Sarcoma
8%
Sterol Regulatory Element Binding Protein 1c
8%
Stomach Cancer
12%
Stomach Tumor
8%
Thromboplastin
8%
Transcriptome
10%
Transcriptome
6%
Tumor Growth
24%